187 related articles for article (PubMed ID: 3356638)
21. [Analysis of muscarinic receptors on rat pancreatic acini by using 125I-quinuclidinyl benzilate and N-[3H]-methylscopolamine].
Aoki E; Adachi H; Noguchi M; Satoh S; Ohnishi S; Honda T; Konishi J
Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1571-8. PubMed ID: 1942611
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
[TBL] [Abstract][Full Text] [Related]
23. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
24. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
Brown JH; Goldstein D
J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
[TBL] [Abstract][Full Text] [Related]
25. Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors.
Harden TK; Petch LA; Traynelis SF; Waldo GL
J Biol Chem; 1985 Oct; 260(24):13060-6. PubMed ID: 4055732
[TBL] [Abstract][Full Text] [Related]
26. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
Wreggett KA; Wells JW
J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
[TBL] [Abstract][Full Text] [Related]
27. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
28. Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 2. Effects of antagonists.
Murali Mohan P; Yang CM; Dwyer TM; Farley JM
J Auton Pharmacol; 1988 Jun; 8(2):107-17. PubMed ID: 2459126
[TBL] [Abstract][Full Text] [Related]
29. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
30. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
Lee JH; el-Fakahany EE
Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line.
Ray P; Middleton W; Berman JD
J Neurochem; 1989 Feb; 52(2):402-9. PubMed ID: 2562988
[TBL] [Abstract][Full Text] [Related]
32. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
33. Characterization of muscarinic cholinergic receptors in cat tracheal gland cells.
Culp DJ; Marin MG
J Appl Physiol (1985); 1986 Oct; 61(4):1375-82. PubMed ID: 3781953
[TBL] [Abstract][Full Text] [Related]
34. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
[TBL] [Abstract][Full Text] [Related]
35. Pirenzepine block of ACH-induced mucus secretion in tracheal submucosal gland cells.
Farley JM; Dwyer TM
Life Sci; 1991; 48(1):59-67. PubMed ID: 1986183
[TBL] [Abstract][Full Text] [Related]
36. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
38. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
[TBL] [Abstract][Full Text] [Related]
39. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
